exetimibe

Could a PCSK9 inhibitor treat YOUR cholesterol soon?

 

Climbing the mountain toward EU

and US approval is a new cholesterol treatment called evolocumab (no name yet other than AMG-145). Have you heard of the PCSK9 inhibitor family? Probably not, but it’s worth a closer look and the Amgen molecule may be the first out of the box.

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.